China Universal Asset Management Co., Ltd. Altimmune, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.23 Billion
- Q4 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Altimmune, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,003 shares of ALT stock, worth $70,902. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,003
Previous 15,470
9.91%
Holding current value
$70,902
Previous $58,000
20.69%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ALT
# of Institutions
193Shares Held
43.4MCall Options Held
3.78MPut Options Held
2.8M-
Vanguard Group Inc Valley Forge, PA9.49MShares$39.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.32MShares$22.2 Million0.0% of portfolio
-
State Street Corp Boston, MA3.6MShares$15 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.13MShares$8.89 Million0.37% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$8.41 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $204M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...